hydroquinone has been researched along with Erythema in 12 studies
Erythema: Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Hydroquinone (HQ) is the gold standard and remains the only prescription product available in the United States for the treatment of generalized facial hyperpigmentation." | 9.17 | Evaluation of a hydroquinone-free skin brightening product using in vitro inhibition of melanogenesis and clinical reduction of ultraviolet-induced hyperpigmentation. ( Banga, A; Jain, P; Makino, ET; Mehta, RC; Sigler, ML; Sonti, S, 2013) |
| "In this prospective pilot study, we evaluated the efficacy and safety for a novel combination therapy based on low-fluence Q-switched 1064 nm Nd:YAG laser, hydroquinone cream and oral tranexamic acid for recalcitrant Riehl's melanosis." | 7.85 | A pilot study for triple combination therapy with a low-fluence 1064 nm Q-switched Nd:YAG laser, hydroquinone cream and oral tranexamic acid for recalcitrant Riehl's Melanosis. ( Choi, SC; Jung, JY; Kwon, HH; Kwon, IH; Ohn, J; Park, GH; Park, HY; Suh, DH, 2017) |
| "To evaluate the erythema and pigmentation of melasma lesions and the surrounding areas in patients receiving triple combination (TC: hydroquinone, tretinoin, and fluocinolone acetonide) regimens." | 5.19 | Objective assessment of erythema and pigmentation of melasma lesions and surrounding areas in long-term management regimens with triple combination. ( Fernandes, JD; Hexsel, D; Siega, C; Soirefmann, M, 2014) |
| " Hydroquinone (HQ) is the gold standard and remains the only prescription product available in the United States for the treatment of generalized facial hyperpigmentation." | 5.17 | Evaluation of a hydroquinone-free skin brightening product using in vitro inhibition of melanogenesis and clinical reduction of ultraviolet-induced hyperpigmentation. ( Banga, A; Jain, P; Makino, ET; Mehta, RC; Sigler, ML; Sonti, S, 2013) |
| "To evaluate the efficiency and adverse effects of 10% all-trans retinol (ROL) gel for improvement of skin hyperpigmentation." | 5.10 | Clinical trial of bleaching treatment with 10% all-trans retinol gel. ( Aiba, E; Aoyama, T; Harii, K; Iga, T; Matsumoto, D; Mitoma, Y; Momosawa, A; Sato, K; Yoshimura, K, 2003) |
| "In this prospective pilot study, we evaluated the efficacy and safety for a novel combination therapy based on low-fluence Q-switched 1064 nm Nd:YAG laser, hydroquinone cream and oral tranexamic acid for recalcitrant Riehl's melanosis." | 3.85 | A pilot study for triple combination therapy with a low-fluence 1064 nm Q-switched Nd:YAG laser, hydroquinone cream and oral tranexamic acid for recalcitrant Riehl's Melanosis. ( Choi, SC; Jung, JY; Kwon, HH; Kwon, IH; Ohn, J; Park, GH; Park, HY; Suh, DH, 2017) |
| "Tranexamic acid (TA) is a relatively new brightening agent that interferes with keratinocyte-melanocyte interactions." | 2.87 | Comparing the efficacy of topical hydroquinone 2% versus intradermal tranexamic acid microinjections in treating melasma: a split-face controlled trial. ( Darayesh, M; Heiran, A; Saki, N, 2018) |
| " HQ was introduced into these formulations to provide a safe and effective alternative to mercury and other less effective ingredients." | 1.30 | Lack of nephrotoxicity and renal cell proliferation following subchronic dermal application of a hydroquinone cream. ( David, RM; English, JC; Moyer, C; O'Donoghue, JL; Totman, LC, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chalermchai, T | 1 |
| Rummaneethorn, P | 1 |
| Saki, N | 1 |
| Darayesh, M | 1 |
| Heiran, A | 1 |
| Makino, ET | 1 |
| Mehta, RC | 1 |
| Banga, A | 1 |
| Jain, P | 1 |
| Sigler, ML | 1 |
| Sonti, S | 1 |
| Hexsel, D | 2 |
| Hexsel, C | 1 |
| Porto, MD | 1 |
| Siega, C | 2 |
| Soirefmann, M | 1 |
| Fernandes, JD | 1 |
| Imhof, L | 1 |
| Dummer, R | 1 |
| Dreier, J | 1 |
| Kolm, I | 1 |
| Barysch, MJ | 1 |
| Kwon, HH | 1 |
| Ohn, J | 1 |
| Suh, DH | 1 |
| Park, HY | 1 |
| Choi, SC | 1 |
| Jung, JY | 1 |
| Kwon, IH | 1 |
| Park, GH | 1 |
| Yoshimura, K | 1 |
| Momosawa, A | 1 |
| Aiba, E | 1 |
| Sato, K | 1 |
| Matsumoto, D | 1 |
| Mitoma, Y | 1 |
| Harii, K | 1 |
| Aoyama, T | 1 |
| Iga, T | 1 |
| Apfelberg, DB | 1 |
| David, RM | 1 |
| English, JC | 1 |
| Totman, LC | 1 |
| Moyer, C | 1 |
| O'Donoghue, JL | 1 |
| Chess, C | 1 |
| Goldman, MP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| OneDoc Picopulse™ for the Treatment of Melasma Among Malaysian Women[NCT04834167] | 32 participants (Actual) | Interventional | 2021-05-01 | Completed | |||
| Comparing Tranexamic Acid Microinjection Alone Versus Its Combination With Fractional Carbon Dioxide Laser in Melasma Treatment[NCT03899233] | Phase 4 | 25 participants (Anticipated) | Interventional | 2019-04-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for hydroquinone and Erythema
| Article | Year |
|---|---|
The use of hydroquinone with facial laser resurfacing.
Topics: Erythema; Humans; Hydroquinones; Hyperpigmentation; Laser Therapy; Lasers; Radiation-Protective Agen | 2000 |
7 trials available for hydroquinone and Erythema
| Article | Year |
|---|---|
Effects of a fractional picosecond 1,064 nm laser for the treatment of dermal and mixed type melasma.
Topics: Adult; Erythema; Female; Humans; Hydroquinones; Lasers, Solid-State; Low-Level Light Therapy; Melano | 2018 |
Comparing the efficacy of topical hydroquinone 2% versus intradermal tranexamic acid microinjections in treating melasma: a split-face controlled trial.
Topics: Administration, Topical; Adult; Erythema; Face; Female; Humans; Hydroquinones; Melanins; Melanosis; | 2018 |
Evaluation of a hydroquinone-free skin brightening product using in vitro inhibition of melanogenesis and clinical reduction of ultraviolet-induced hyperpigmentation.
Topics: Administration, Cutaneous; Adult; Dermatologic Agents; Dose-Response Relationship, Radiation; Double | 2013 |
Triple combination as adjuvant to cryotherapy in the treatment of solar lentigines: investigator-blinded, randomized clinical trial.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Chemotherapy, Adjuvant; Cryotherapy; | 2015 |
Objective assessment of erythema and pigmentation of melasma lesions and surrounding areas in long-term management regimens with triple combination.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antioxidants; Drug Therapy, Combination; Erythema; Fluo | 2014 |
A Prospective Trial Comparing Q-Switched Ruby Laser and a Triple Combination Skin-Lightening Cream in the Treatment of Solar Lentigines.
Topics: Aged; Dexamethasone; Drug Combinations; Erythema; Female; Hand Dermatoses; Humans; Hydroquinones; La | 2016 |
Clinical trial of bleaching treatment with 10% all-trans retinol gel.
Topics: Adult; Aged; Ascorbic Acid; Dermatitis, Irritant; Drug Therapy, Combination; Erythema; Female; Gels; | 2003 |
4 other studies available for hydroquinone and Erythema
| Article | Year |
|---|---|
A pilot study for triple combination therapy with a low-fluence 1064 nm Q-switched Nd:YAG laser, hydroquinone cream and oral tranexamic acid for recalcitrant Riehl's Melanosis.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Combined Modality Therapy; Erythema; Facial | 2017 |
Ultrapulse carbon dioxide laser with CPG scanner for full-face resurfacing for rhytids, photoaging, and acne scars.
Topics: Acne Vulgaris; Acyclovir; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antiviral Agents | 1997 |
Lack of nephrotoxicity and renal cell proliferation following subchronic dermal application of a hydroquinone cream.
Topics: Administration, Cutaneous; Animals; Cell Division; Erythema; Female; gamma-Glutamyltransferase; Hydr | 1998 |
Nothing like a little science now and then.
Topics: Erythema; Glycolates; Humans; Hydroquinones; Keratolytic Agents; Laser Therapy; Lasers; Pigmentation | 1999 |